What is the present valuation and projected CAGR of the neurocognitive assessment and rehabilitation market?
The neurocognitive assessment and rehabilitation market size has grown strongly in recent years. It will grow from $13.4 billion in 2024 to $14.7 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to an increased incidence of neurocognitive disorders, an aging population, increased awareness, and education, healthcare policy and funding, improved diagnostic techniques, and a rise in mental health issues.
The neurocognitive assessment and rehabilitation market size is expected to see strong growth in the next few years. It will grow to $21 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to personalized medicine approaches, corporate wellness programs, technological advancements, insurance coverage and reimbursement improvements, and integration with telehealth. Major trends in the forecast period include wearable technology adoption, regenerative medicine, and neuroplasticity research, personalized rehabilitation programs, virtual reality (VR) and augmented reality (AR) utilization, and interdisciplinary approaches.
Get Your Free Sample of The Global Neurocognitive Assessment And Rehabilitation Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15870&type=smp
Which Market drivers have played a significant role in driving the neurocognitive assessment and rehabilitation market?
The increasing prevalence of neurological disorders is expected to propel the growth of the neurocognitive assessment and rehabilitation market going forward. Neurological disorders are medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, leading to symptoms such as muscle weakness, coordination problems, and cognitive impairments. Neurological disorders can be attributed to a combination of factors with an aging population and the prevalence of age-related conditions such as Alzheimer’s disease and Parkinson’s disease. Neurocognitive assessment provides insights into cognitive function, aiding in diagnosis and treatment planning for neurological disorders, while rehabilitation interventions aim to optimize neural functioning and enhance quality of life through targeted therapies and strategies. For instance, according to the Alzheimer’s Association, a US-based voluntary health organization, the prevalence of Alzheimer’s dementia, a neurological disorder, among US individuals people aged 85 and older is projected to reach 2.4 million people in 2024, and expected to rise further to 6.7 million by 2060. Therefore, the increasing prevalence of neurological disorders drives the growth of the neurocognitive assessment and rehabilitation market.
What are the key segments within the neurocognitive assessment and rehabilitation market?
The neurocognitive assessment and rehabilitation market covered in this report is segmented –
1) By Components: Neurocognitive Assessment Testing, Neurorehabilitation Therapy
2) By Providers: Rehab Centers, Hospital And Clinics, Homecare Settings, Physiotherapy Centers
3) By Organization Size: Large Enterprises, Small And Medium-sized Enterprises (SMEs)
Subsegments:
1) By Neurocognitive Assessment Testing: Standardized Tests, Computerized Neurocognitive Assessments, Paper-Based Neurocognitive Tests
2) By Neurorehabilitation Therapy: Cognitive Behavioral Therapy (CBT), Virtual Reality Therapy, Transcranial Magnetic Stimulation (TMS), Neurofeedback Therapy, Physical Therapy And Occupational Therapy
Order your report now for swift delivery
Which key players are shaping the neurocognitive assessment and rehabilitation market?
Major companies operating in the neurocognitive assessment and rehabilitation market are Cogstate Ltd., Posit Science Corporation, Lumos Labs Inc., The Magstim Company Ltd., MindMaze SA, CogniFit Inc., Cambridge Cognition Holdings plc, ImPACT Applications Inc., Neurotrack Technologies Inc., Neuroelectrics Corporation, SCHUHFRIED GmbH, Constant Therapy Health Inc., NeuronUP S.L., Qbtech AB, Neurometrix Inc., CogniVue Corporation, Neurohealth Associates LLP, BrainTrain Inc., NeuroEM Therapeutics Inc., HASOMED GmbH, Neurosoft Bioelectronics Corporation, AnthroTronix Inc., Flow Neuroscience AB, NPsych Limited
Which transformative trends will shape the neurocognitive assessment and rehabilitation market landscape?
Major companies operating in the neurocognitive assessment and rehabilitation market are developing innovative solutions, such as digital tests, to screen cognitive impairment and gain a competitive edge. Digital tests refer to assessments conducted using digital platforms or software to evaluate various cognitive functions such as memory, attention, language, and executive function. For instance, in November 2022, Neurotrack Technologies, a US-based company that provides web-based screening tools and cognitive health programs, launched a 3-minute digital test to screen for cognitive impairment. This tool enables primary care teams to swiftly screen for cognitive decline during annual wellness visits, aiding in the early detection of neurodegenerative diseases, including Alzheimer’s. It has culturally-agnostic features that enhance accuracy and accessibility, addressing the critical need for cognitive screening amidst an aging population. This innovative solution empowers providers to integrate cognitive testing seamlessly into clinical workflows, potentially revolutionizing dementia care and intervention strategies.
How do regional factors impact the neurocognitive assessment and rehabilitation market, and which region is the largest contributor?
North America was the largest region in the neurocognitive assessment and rehabilitation market in 2024. The regions covered in the neurocognitive assessment and rehabilitation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Neurocognitive Assessment And Rehabilitation Market Report 2025 Offer?
The neurocognitive assessment and rehabilitation market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Neurocognitive rehabilitation refers to therapeutic interventions aimed at diagnosing and treating cognitive impairments caused by neurological conditions, brain injuries, or psychological disorders. It involves a series of standardized tests and clinical evaluations designed to measure cognitive functions such as memory, attention, language, and problem-solving skills.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15870
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
